Gyon Technologies Capital Management, LP Insmed Inc Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $257,346 - $332,493	-9,940 Closed	0 $0
Q3 2021 Nov 18, 2021	SELL	$22.46 - $29.47 $1.13 Million - $1.48 Million	-50,356 Reduced 83.51%	9,940 $274,000
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $1.26 Million - $1.88 Million	52,129 Added 638.29%	60,296 $1.72 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $263,630 - $361,798	8,167 New	8,167 $278,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $502,854 - $648,194	-15,989 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $415,714 - $551,620	15,989 New	15,989 $514,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.